![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/282 | |
A61K 31/337 | |||
A61K 31/4745 | |||
A61K 31/513 | |||
A61K 31/519 | |||
A61K 31/704 | |||
A61K 31/7068 | |||
A61K 33/24 | |||
A61K 45/06 | |||
A61K 31/4412 | |||
A61K 31/4965 | |||
A61K 31/506 |
(11) | Number of the document | 2435041 |
(13) | Kind of document | T |
(96) | European patent application number | 10723967.5 |
Date of filing the European patent application | 2010-05-21 | |
(97) | Date of publication of the European application | 2012-04-04 |
(45) | Date of publication and mention of the grant of the patent | 2016-12-28 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2010/057027 |
Date | 2010-05-21 |
(87) | Number | WO 2010/136394 |
Date | 2010-12-02 |
(30) | Number | Date | Country code |
09161111 | 2009-05-26 | EP |
(72) |
VALSASINA, Barbara, IT
BERIA, Italo, IT
CIAVOLELLA, Antonella, IT
BALLINARI, Dario, IT
PESENTI, Enrico, IT
MOLL, Juergen, IT
|
(73) |
Nerviano Medical Sciences S.r.l.,
11 Viale Pasteur, 10 P.O. Box 11, 20014 Nerviano (MI),
IT
|
(54) | Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent |
Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent |